Abstract
Schizophrenia is a major psychiatric illness whose definition has varied with respect to both time and country. Thus, the “schizophrenia” referred to in the American literature of the late 1960s was different from that defined by the British psychiatric profession of the same era and different also from the accepted definitions in the United States today. This evolution of the schizophrenia construct makes it problematic to apply the literature from disparate places and eras to the modern schizophrenia patient.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Addad, M., Benezech, M., Bourgeois, M., & Yesavage, J. (1981). Criminal acts among schizophrenics in French mental hospitals. Journal of Nervous and Mental Disease, 169, 289–293.
Arana, G. W, Ornstein, M. L., Kanter, E, Friedman, H. L., Greenblatt, D. J., & Shader, R. I. (1986). The use of benzodiazepines for psychotic disorders: A literature review and preliminary clinical findings. Psychopharmacology Bulletin, 22, 77–87.
Atsmon, A., Blum, I., Wijsenbeek, H., Maoz, B., Steiner, M., & Ziegelman, G. (1971). Short-term effects of adrenergic-blocking agents in a small group of psychotic patients: Preliminary clinical observations. Psychiatria, Neurologia, Neurochirurgia,74,251–258.
Baldessarini, R. J., Cohen, B. M., & Teicher, M. H. (1988). Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses. Archives of General Psychiatry, 45, 79–90.
Barber, J. W., Hundley, P., Kellogg, E., Glick, J. L., Godleski, L., Kerler, R., & Vieweg, W. V. R. (1988). Clinical and demographic characteristics of 15 patients with repetitively assaultive behavior. Psychiatric Quarterly,59, 213–224.
Beisser, A. R., & Blanchette, J. E. (1961). A study of suicides in a mental hospital. Diseases of the Nervous System, 22, 365–369.
Benezech, M., Bourgeois, M., & Yesavage, J. (1980). Violence in the mentally ill: A study of 547 patients at a French hospital for the criminally insane. Journal of Nervous and Mental Disease, 168,698–700.
Biederman, J., Lerner, Y., & Belmaker, R. H. (1979). Combination of lithium carbonate and haloperidol in schizoaffective disorder: A controlled study. Archives of General Psychiatry, 36, 327–333.
Blackburn, R. (1968). Emotionality, extraversion and aggression in paranoid and nonparanoid schizophrenic offenders. British Journal of Psychiatry, 114, 1301–1302.
Bowers, M. B., & Astrachan, B. M. (1967). Depression in acute schizophrenic psychosis. American Journal of Psychiatry, 123, 976–979.
Breier, A., & Astrachan, B. M. (1984). Characterization of schizophrenic patients who commit suicide. American Journal of Psychiatry, 141, 206–209.
Campbell, R., & Simpson, G. M. (1986). Alternative approaches in the treatment of psychotic agitation. Psychosomatics, 27, 23–26.
Carone, B. J., Harrow, M., & Westermeyer, J. E (1991). Posthospital course and outcome in schizophrenia. Archives of General Psychiatry, 48, 247–253.
Cheng, K. K., Leung, C. M., Lo, W. H., & Lam, T. H. (1990). Risk factors of suicide among schizophrenics. Acta Psychiatrica Scandinavica, 81, 220–224.
Cohen, S., Leonard, C. V., Farberow, N. L., & Shneidman, E. S. (1964). Tranquilizers and suicide in the schizophrenic patient. Archives of General Psychiatry, 11, 312–321.
Craig, T. J. (1982). Violence among psychiatric inpatients: An epidemiologic study of problems associated with violence among psychiatric inpatients. American Journal of Psychiatry, 139, 1262–1266.
Diamond, R. (1985). Drugs and the quality of life: The patient’s point of view. Journal of Clinical Psychiatry, 42, 636–637.
Docherty, J. P., Van Kammen, D. P., Skis, S. G., & Marder, S. R. (1978). Stages of onset of schizophrenic psychosis. American Journal of Psychiatry, 135, 420–426.
Donlon, P. T., & Blacker, K. H. (1973). Stages of schizophrenia decompensation and reintegration. Journal of Nervous and Mental Disease, 157, 200–208.
Drake, R. E., Gates, C., Whitaker, A., & Cotton, P. G. (1985). Suicide among schizophrenics: A review. Comprehensive Psychiatry, 26, 90–100.
Drake, R. E., Gates, C., & Cotton, P. G. (1986). Suicide among schizophrenics: A comparison of attempters and completed suicides. British Journal of Psychiatry, 149, 784–787.
Dyck, R. J., Bland, R. C., Newman, S. C., & Orn, H. (1988). Suicide attempts and psychiatric disorders in Edmonton. Acta Psychiatrica Scandinavica, 77 (Suppl. 338), 64–71.
Eichelmann, B. (1987). Neurochemical bases of aggressive behavior. Psychiatric Annals, 17, 371–374.
Farberow, N. L., Shneidman, E. S., & Leonard, C. V. (1961). Suicide among schizophrenic mental hospital patients. In N. L. Farberow & E. S. Shneidman (Eds.), The cry for help (pp. 78–109). New York/Toronto/London: McGraw-Hill Books.
Fouks, L. (1967). Originalite et specificite de la fluphenazine. In Proceedings of the Fifth International Congress of Neuropsychopharmacology (International Congress Series #192, pp. 1128–1134). Amsterdam: Exerpta Medica Foundation.
Greenfield, T. K., McNiel, D. E., & Binder, R. L. (1989). Violent behavior and length of psychiatric hospitalization. Hospital and Community Psychiatry, 40, 809–814.
Greilsheimer, H., & Groves, J. E. (1979). Male genital self-mutilation. Archives of General Psychiatry, 36, 441–446.
Gundlach, R., Engelhardt, D. M., Hankoff, L., Paley, H., Rudorfer, L., & Bird, E. (1966). A double-blind outpatient study of diazepam (Valium) and placebo. Psychopharmacology, 9, 81–92.
Hakola, H. P. A., & Laulumaa, V. A. (1982, June 12). Carbamazepine in treatment of violent schizophrenics. Lancet, p. 1358.
Herrera, J. N., Sramek, J. J., Costa, J. F., Roy, S., Heh, C. W., & Nguyen, B. N. (1988). High potency neuroleptics and violence in schizophrenia. Journal of Nervous and Mental Disease, 176, 558–561.
Hirschowitz, J., Casper, R., & Garver, D. L. (1980). Lithium response in good prognosis schizophrenia. American Journal of Psychiatry, 137, 916–920.
Hollister, L. E., Bennett, J. L., Kimbell, I., Jr., Savage, C., & Overall, J. E. (1963). Diazepam in newly admitted schizophrenics. Diseases of the Nervous System, 24, 746–750.
Hussar, A. E. (1962). Effect of tranquilizers on medical morbidity and mortality in a mental hospital. Journal of the American Medical Association, 179, 682–686.
Jimerson, D. C., Van Kammen, D. P, Post, R. M., Docherty, J. P., & Bunney, W. E., Jr. (1982). Diazepam in schizophrenia: Preliminary double-blind trial. American Journal of Psychiatry, 139, 489–491.
Johnson, D. A. W (1981). Studies of depressive symptoms in schizophrenia: I. The prevalence of depression and its possible causes. British Journal of Psychiatry, 139, 89–101.
Kahn, E. M., Schulz, S. C., Perel, J. M., & Alexander, J. E. (1990). Change in haloperidol level due to carbamazepine: A complicating factor in combined medication for schizophrenia. Journal of Clinical Psychopharmacology, 10, 54–57.
Kane, J., Honigfeld, G., Singer, J., Meltzer, H., & the Clozaril Collaborative Study Group. (1988). Clozapine for the treatment-resistant schizophrenic: A double-blind comparison with chlorpromazine. Archives of General Psychiatry, 45, 789–796.
Kaplan, H. I., & Sadock, B. J. (Eds.). (1989). Comprehensive textbook of psychiatry (Vol. 5). Baltimore: Williams & Wilkins.
Karson, C., & Bigelow, L. B. (1987). Violent behavior in schizophrenic inpatients. Journal of Nervous and Mental Disease, 175, 161–164.
Karson, C. N., Weinberger, D. R., Llewellyn, B., & Wyatt, R. J. (1982). Clonazepam treatment of chronic schizophrenia: Negative results in a double-blind, placebo-controlled trial. American Journal of Psychiatry, 139, 1627–1628.
Keats, M. M., & Mukherjee, S. (1988). Antiaggressive effect of adjunctive clonazepam in schizophrenia-Associated with seizure disorder. Journal of Clinical Psychiatry, 49, 117–118.
Keepers, G. A., Clappison, V. J., & Casey, D. E. (1983). Initial anticholinergic prophylaxis for neurolepticinduced extrapyramidal syndromes. Archives of General Psychiatry, 40, 1113–1117.
Kellner, R., Wilson, R. M., Muldawer, M. D., & Pathak, D. (1975). Anxiety in schizophrenia: Responses to chlordiazepoxide in an intensive design study. Archives of General Psychiatry, 32, 1246–1254.
Kidron, R., Averbuch, I., Klein, E., & Belmaker, R. H. (1985). Carbamazepine-induced reduction of blood levels of haloperidol in chronic schizophrenia. Biological Psychiatry, 20, 219–222.
Klein, D. F., & Davis, J. M. (1969). Diagnosis and drug treatment of psychiatric disorders. Baltimore: Williams & Wilkins.
Klein, E., Bental, E., Lerer, B., & Belmaker, R. H. (1984). Carbamazepine and haloperidol v placebo and haloperidol in excited psychoses: A controlled study. Archives of General Psychiatry, 41, 165–170.
Krakowski, M., Volavka, J., & Brizer, D. (1986). Psychopathology and violence: A review of literature. Comprehensive Psychiatry, 27,131–148.
Krakowski, M., Convit, A., & Volavka, J. (1988). Patterns of inpatient assaultiveness: Effect of neurological impairment and deviant family environment on response to treatment. Neuropsychiatry, Neuropsychology, and Behavioral Neurology, 1, 21–29.
Lanzkron, J. (1963). Murder and insanity: A survey. American Journal of Psychiatry, 119, 754–758.
Lemus, C. Z., Lieberman, J. A., Johns, C. A., Pollack, S., Bookstein, P., & Cooper, T. B. (1990). CSF 5-hydroxy-indoleacetic acid levels and suicide attempts in schizophrenia. Biological Psychiatry, 27, 926–929.
Levy, A. B., Kurtz, N., & Kling, A. S. (1984). Association between cerebral ventricular enlargement and suicide attempts in chronic schizophrenia. American Journal of Psychiatry, 141, 438–439.
Levy, S., & Southcombe, R. H. (1953). Suicide in a state hospital for the mentally ill. Journal of Nervous and Mental Disease, 117, 504–514.
Lindstrom, L. H., & Persson, E. (1980). Propranolol in chronic schizophrenia: A controlled study in neuroleptictreated patients. British Journal of Psychiatry, 137, 126–130.
Lingjaerde, O. (1982). Effect of the benzodiazepine derivative estazolam in patients with auditory hallucinations: A multicentre double-blind, cross-over study. Acta Psychiatrica Scandinavica, 65, 339–354.
Lion, J. R., & Pasternak, S. A. (1973). Countertransference reactions to violent patients. American Journal of Psychiatry, 130, 207–210.
Luchins, D. J. (1984). Carbamazepine in violent non-epileptic schizophrenics. Psychopharmacology Bulletin, 20 569–571.
MacKinnon, B. L. (1977). Postpsychotic depression and the need for personal significance. American Journal of Psychiatry. 134, 427–429.
Madden, D. J., Lion, J. R., & Penna, M. W. (1976). Assaults on psychiatrists by patients. American Journal of Psychiatry, 133, 422–425.
Manscheck, T. C., & Ames, D. (1984). Neurologic features and psychopathology in schizophrenic disorders. Biological Psychiatry, 19, 703–719.
Marder, S. R., Van Putten, T., Mintz, J., McKenzie, J., Labell, M., Faltico, G., & May, P. R. A. (1984). Costs and benefits of two doses of fluphenazine. Archives of General Psychiatry, 41,1025–1029.
McGlashan, T. H., & Carpenter, W. T. (1976). An investigation of the postpsychotic depressive syndrome. American Journal of Psychiatry, 133,14–19.
Myers, D. H., Campbell, P. L., Cocks, N. M., Flowerdew, J. A., & Muir, A. (1981). A trial of propranolol in chronic schizophrenia. British Journal of Psychiatry, 139,118–121.
Myers, K. M., & Dunner, D. L. (1984). Self and other directed violence on a closed acute-care ward. Psychiatric Quarterly, 56, 178–188.
Neppe, V. M. (1983). Carbamazepine as adjunctive therapy in nonepileptic chronic inpatients with EEG temporal lobe abnormalities. Journal of Clinical Psychiatry, 44, 326–331.
Neppe, V. M. (1988). Carbamazepine in nonresponsive psychosis. Journal of Clinical Psychiatry, 49, 22–28.
Ninan, P. T., Van Kammen, D. P., Scheinin, M., Linnoila, M., Bunney, W. E., Jr., & Goodwin, E K. (1984). CSF 5-hydroxyindoleacetic acid levels in suicidal schizophrenic patients. American Journal of Psychiatry, 141, 566–569.
Nyman, A. K., & Jonsson, H. (1986). Patterns of self-destructive behaviour in schizophrenia. Acta Psychiatrica Scandinavica, 73, 252–262.
Oltman, J. E., & Friedman, S. (1941). A psychiatric study of one hundred criminals-with particular reference to the psychological determinants of crime. Journal of Nervous and Mental Disease, 93, 16–41.
Pearson, M., Wilmot, E., & Padi, M. (1986). A study of violent behavior among in-patients in a psychiatric hospital. British Journal of Psychiatry, 149, 232–235.
Peet, M., Bethell, M. S., Coates, A., Khamnee, A. K., Hall, P., Cooper, S. J., King, D. J., & Yates, R. A. (1981). Propranolol in schizophrenia. I. Comparison of propranolol, chlorpromazine and placebo. British Journal of Psychiatry,139,105–111.
Piacente, G. J. (1986). Aggression. Neuropsychiatry, 9, 329–339.
Planansky, K., & Johnston, R. (1971). Occurrence and characteristics of suicidal preoccupation and acts in schizophrenia. Acta Psychiatrica Scandinavica, 47, 473–483.
Planansky, K., & Johnston, R. (1977). Homicidal aggression in schizophrenic men. Acta Psychiatrica Scandinavica, 55, 65–73.
Pollock, H. M. (1938). Is the paroled patient a menace to the community? The Psychiatric Quarterly, 12, 236–244.
Pugh, C. R., Steinert, J., & Priest, R. G. (1983). Propranolol in schizophrenia: A double blind, placebo controlled trial of propranolol as an adjunct to neuroleptic medication. British Journal of Psychiatry, 143,151–155.
Quitkin, E, Rifkin, A., & Klein, D. E (1975). Very high dosage vs. standard dosage fluphenazine in schizophrenia: Double-blind study of nonchronic treatment-refractory patients. Archives of General Psychiatry, 32,1276–1281.
Quitkin, F, Rifkin, A., & Klein, D. E (1976). Neurologic soft signs in schizophrenia and character disorders. Archives of General Psychiatry, 33, 845–853.
Rada, R. T., & Donlon, P. T. (1975). Depression and the acute schizophrenic process. Psychosomatics, 16, 116–119.
Rappeport, J. R., & Lassen, G. (1965). Dangerousness-Arrest rate comparisons of discharged patients and the general population. American Journal of Psychiatry,121,776–783.
Rennie, T. (1939). Follow-up study of five hundred patients with schizophrenia admitted to the hospital from 1913 to 1923. Archives of Neurology, 42, 877–891.
Rifkin, A., & Siris, S. (1987). Drug treatment of acute schizophrenia. In H. Y. Meltzer (Ed.), Psychopharmacology: The third generation of progress (pp. 1095–1101). New York: Raven Press.
Rifkin, A., Quitkin, E, & Klein, D. E (1975). Akinesia, a poorly recognized drug-induced extrapyramidal behavioral disorder. Archives of General Psychiatry, 32, 672–674.
Robertson, G. (1988). Arrest patterns among mentally disordered offenders. British Journal of Psychiatry, 153, 313–316.
Rollin, H. R. (1965). Unprosecuted mentally abnormal offenders. British Medical Journal, 1, 831–835.
Rossi, A. M., Jacobs, M., Monteleone, M., Olsen, R., Surber, R. W., Winkler, E. L., & Wommack, A. (1986). Characteristics of psychiatric patients who engage in assaultive or other fear-inducing behaviors. Journal of Nervous and Mental Disease,174,154–160.
Roth, S. (1970). The seemingly ubiquitous depression following acute schizophrenic episodes, a neglected area of clinical discussion. American Journal of Psychiatry, 127, 91–98.
Roy, A. (1982). Suicide in chronic schizophrenia. British Journal of Psychiatry, 141, 171–177.
Roy, A. (1986). Depression, attempted suicide, and suicide in patients with chronic schizophrenia. Psychiatric Clinics of North America, 9, 193–206.
Roy, A., Mazonson, A., & Pickar, D. (1984). Attempted suicide in chronic schizophrenia. British Journal of Psychiatry, 144, 303–306.
Roy, A., Ninan, P, Mazonson, A., Pickar, D., Van Kammen, D., Linnoila, M., & Paul, S. M. (1985). CSF monoamine metabolites in chronic schizophrenic patients who attempt suicide. Psychological Medicine, 15, 335–340.
Salama, A. A. (1988). Depression and suicide in schizophrenic patients. Suicide and Life-Threatening Behavior, 18, 379–384.
Salzman, C., Green, A. I., Rodriguez-Villa, E, & Jaskiw, G. I. (1986). Benzodiazepines combined with neuroleptics for management of severe disruptive behavior. Psychosomatics, 27, 17–21.
Semrad, E. V. (1966). Long-term therapy of schizophrenia. In E. L. Usdin (Ed.), Psychoneuroses and schizophrenia (pp. 155–156). Philadelphia: J. B. Lippincott.
Shader, R. I., Jackson, A. H., Harmatz, J. S., & Appelbaum, P S. (1977). Patterns of violent behavior among schizophrenic inpatients. Diseases of the Nervous System, 38, 13–16.
Shaffer, J. W., Perlin, S., Schmidt, C. W, & Stephens, J. H. (1974). Prediction of suicide in schizophrenia. Journal of Nervous and Mental Disease, 159, 349–355.
Sheppard, G. P (1979). High-dose propranolol in schizophrenia. British Journal of Psychiatry, 134, 470–476.
Silverman, D. (1943). Psychoses in criminals: A study of five hundred psychotic prisoners. Journal of Criminal Psychopathology, 4, 703–723.
Simpson, G. M., Varga, E., & Haber, E. J. (1976). Psychotic exacerbations produced by neuroleptics. Diseases of the Nervous System, 37, 367–369.
Siris, S. G., Van Kammen, D. P., & Docherty, J. P (1978). Use of antidepressant drugs in schizophrenia. Archives of General Psychiatry, 35, 1368–1377.
Small, J. G., Kellams, J. J., Milstein, V., & Moore, J. (1975). Placebo-controlled study of lithium combined with neuroleptics in chronic schizophrenic patients. American Journal of Psychiatry, 132, 1315–1317.
Sramek, J., Herrera, J., Costa, J., Heh, C., Tran-Johnson, T., & Simpson, G. (1988). A carbamazepine trial in chronic, treatment-refractory schizophrenia. American Journal of Psychiatry, 145, 748–750.
Tardiff, K. (1984). Characteristics of assaultive patients in private hospitals. American Journal of Psychiatry, 141, 1232–1235.
Tardiff, K. (1989). Concise guide to assessment and management of violent patients. Washington, DC: APA Press.
Tardiff, K., & Sweillam, A. (1979). The relation of age to assaultive behavior in mental patients. Hospital and Community Psychiatry, 30, 709–711.
Tardiff, K., & Sweillam, A. (1980). Assault, suicide, and mental illness. Archives of General Psychiatry, 37, 164–169.
Tardiff, K., & Sweillam, A. (1982). Assaultive behavior among chronic inpatients. American Journal of Psychiatry, 139, 212–215.
Taylor, P J., & Gunn, J. (1984, June 30). Violence and psychosis. I. Risk of violence among psychotic men. British Medical Journal, 288 (Abstracts from Clinical Research 1945–1952).
Teicher, M. H., & Baldessarini, R. J. (1985). Selection of neuroleptic dosage. Archives of General Psychiatry, 42, 636–637.
Tennent, G., Loucas, K., Fenton, G., & Fenwick, P (1974). Male admissions to Broadmoor Hospital. British Journal of Psychiatry, 125, 44–50.
’Ricker, G. J., Campion, E. W, & Silberfarb, P M. (1975). Sensorimotor functions and cognitive disturbance in psychiatric patients. American Journal of Psychiatry, 132, 17–21.
Van Praag, H. M. (1983, October 22). CSF 5-HIAA and suicide in nondepressed schizophrenics. Lancet, pp. 977–978.
Van Praag, H. M. (1986). (Auto) aggression and CSF 5-HIAA in depression and schizophrenia. Psychopharmacology Bulletin, 22, 669–673.
Van Putten, T. (1975). The many faces of akathisia. Comprehensive Psychiatry, 16, 43–47.
Van Putten, T., & May, P R. A. (1978). Akinetic depression in schizophrenia. Archives of General Psychiatry, 35, 1101–1107.
Van Putten, T., Marder, S. R., May, P. R. A., Poland, R. E., & O’Brien, R. P (1985). Plasma levels of haloperidol and clinical response. Psychopharmacology Bulletin, 21, 69–72.
Van Putten, T., Mutalipassi, L. R., & Malkin, M. D. (1974). Phenothiazine-induced decompensation. Archives of General Psychiatry, 30, 102–105.
Virkkunen, M. (1974). Observations on violence in schizophrenia. Acta Psychiatrica Scandinavica, 50,145–151.
Volavka, J., & Krakowski, M. (1989). Schizophrenia and violence. Psychological Medicine,19, 559–562.
Warnes, H. (1968). Suicide in schizophrenics. Disease of the Nervous System, 29, 35–40.
Wilkinson, G., & Bacon, N. A. (1984). A clinical and epidemiological survey of parasuicide and suicide in Edinburgh schizophrenics. Psychological Medicine, 14, 899–912.
Winchel, R. M., & Stanley, M. (1991). Self-injurious behavior: A review of the behavior and biology of self-mutilation. American Journal of Psychiatry, 148,306–317.
Winokur, G., & Tsuang, M. (1975). The Iowa 500: Suicide in mania, depression, and schizophrenia. American Journal of Psychiatry, 132,650–651.
Wong, S. E., Woolsey, J. E., Innocent, A. J., & Liberman, R. P. (1988). Behavior treatment of violent psychiatric patients. Psychiatric Clinics of North America, 11, 569–580.
Yarden, P. E. (1974). Observations on suicide in chronic schizophrenics. Comprehensive Psychiau y, 15,325–333.
Yesavage, J. A. (1982). Inpatient violence and the schizophrenic patient: An inverse correlation between danger-related events and neuroleptic levels. Biological Psychiatry, 17, 1331–1337.
Yesavage, J. A. (1983). Inpatient violence and the schizophrenic patient: A study of Brief Psychiatric Rating Scale scores and inpatient behavior. Acta Psychiatrica Scandinavica, 67, 353–357.
Yesavage, J. A., Werner, P. D., Becker, J., Holman, C., & Mills, M. (1981). Inpatient evaluation of aggression in psychiatric patients. Journal of Nervous and Mental Disease, 169,299–302.
Yorkston, N. J., Zaki, S. A., Pitcher, D. R., Gruzelier, J. H., Hollander, D., & Sergeant, H. G. S. (1977, September 17). Propranolol as an adjunct to the treatment of schizophrenia. Lancet, pp. 575–578.
Zitrin, A., Hardesty, A. S., Burdock, E. I., & Drossman, A. K. (1976). Crime and violence among mental patients. American Journal of Psychiatry, 133,142–149.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1994 Springer Science+Business Media New York
About this chapter
Cite this chapter
Wirshing, W.C., Ames, D., Marder, S.R., Hicks-Gray, T. (1994). Schizophrenia. In: Hersen, M., Ammerman, R.T., Sisson, L.A. (eds) Handbook of Aggressive and Destructive Behavior in Psychiatric Patients. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-2403-8_13
Download citation
DOI: https://doi.org/10.1007/978-1-4615-2403-8_13
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4613-6019-3
Online ISBN: 978-1-4615-2403-8
eBook Packages: Springer Book Archive